Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.3, 2011-03, pp. : 423-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cystic fibrosis transmembrane regulator (CFTR) modulators

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 471-474

Informa Healthcare

Access to resources Recommend Favorite

New Therapies in Cystic Fibrosis

Current Pharmaceutical Design, Vol. 18, Iss. 5, 2012-02 ,pp. : 614-627

Bentham Science Publishers

Access to resources Recommend Favorite

Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis: Progress to Date

By Becq Frédéric

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 241-259

Adis International

Access to resources Recommend Favorite

Stimulation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels by flavonoids

By Illek B. Machen T.E. Widdicombe J. Fischer H.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite

[(Dihydroindenyl)oxy]alkaonic acid inhibits the cystic fibrosis transmembrane conductance regulator

By Ito Y. Aoyama M. Yamada N. Mizuno Y. Kume H. Yamaki K.

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 175-178

Elsevier

Access to resources Recommend Favorite